Select Medical Clears Antitrust Hurdle in $X Billion Buyout by WCAS-Led Consortium
Event summary
- Hart-Scott-Rodino waiting period expired April 27, 2026 for Select Medical's acquisition by WCAS-led consortium.
- Merger expected to close mid-2026 pending stockholder approval and other customary conditions.
- Select Medical operates 103 critical illness recovery hospitals, 41 rehab hospitals, and 1,912 outpatient clinics across 38 states.
- WCAS manages over $33 billion in committed capital with focus on healthcare and technology sectors.
The big picture
This deal marks another move in the private equity-driven consolidation of U.S. healthcare services, following similar transactions in specialty hospitals and outpatient care. With WCAS's track record of operational improvements, the acquisition could accelerate Select Medical's expansion or trigger competitive responses from other PE-backed platforms.
What we're watching
- Governance Dynamics
- How the consortium's leadership—including Executive Chairman Robert Ortenzio and Martin Jackson—will influence post-merger strategy.
- Regulatory Headwinds
- Whether antitrust scrutiny could emerge at state levels given Select Medical's extensive facility network.
- Execution Risk
- The pace at which integration proceeds and potential disruption to ongoing operations during transition.
Related topics